Drug Shortage Report for LEVITRA

Last updated on 2020-10-19 History
Report ID 113348
Drug Identification Number 02250489
Brand name LEVITRA
Common or Proper name VARDENAFIL
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) VARDENAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4's
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-06-15
Actual start date 2020-06-05
Estimated end date
Actual end date 2020-10-16
Shortage status Resolved
Updated date 2020-10-19
Company comments Product is available to market.
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-10-19 French Compare
v8 2020-10-19 English Compare
v7 2020-06-08 French Compare
v6 2020-06-08 English Compare
v5 2020-06-08 English Compare
v4 2020-06-04 French Compare
v3 2020-06-04 English Compare
v2 2020-04-28 French Compare
v1 2020-04-28 English Compare

Showing 1 to 9 of 9